Ads
-
Related paper
- QSAR Modeling for Relative Toxicity Prediction of (3-(2-chloroquinolin-3-yl)oxiran-2-yl)(phenyl) methanone Derivatives
- QSAR on Heteroaryl-Phenyl-Substituted Pyrazole Derivatives as Selective and Potent Canine COX-2 Inhibitors
- QSAR Modeling for Predicting Anti HIV Activity of PETT Derivatives
- PREDICTIVE QSAR MODELING OF PYRIDAZINYL DERIVATIVES USING K-NEAREST NEIGHBOR AND PHARMACOPHORE APPROACH
- DESIGNING OF GLUTAMATE RECEPTOR INHIBITORS OF QUINAZOLINONE DERIVATIVES BY A COMPARATIVE QSAR ANALYSIS AND MOLECULAR MODELING STUDIES
- LIGAND BASED PHARMACOPHORE MODELING AND QSAR ANALYSIS OF HETEROCYCLIC DIAMIDINE DERIVATIVES AS ANTI-PARASITIC DNA MINOR GROOVE BINDERS
- QSAR Modeling, Molecular Docking, and ADME Studies of Novel 5-Oxo- Imidazoline Derivatives as Anti-Breast Cancer Drug Compounds against MCF-7 Cell Line
- Synthesis and molecular docking of novel N-((2-chloroquinolin-3-yl) methylene)-4-methylbenzenamine derivatives as anti-HIV-1 reverse transcriptase inhibitors
- A 2-D QSAR Modeling, Molecular Docking Study and Design of 2-Arylbenzimidazole Derivatives as Novel Leishmania Inhibitors: A Molecular Dynamics Study
- DOCKING STUDY OF NOVEL N-SUBSTITUTED 2,5-BIS[(7-CHLOROQUINOLIN-4-YL)AMINO]PENTANOIC DERIVATIVES AS SELECTIVE HIGH-BINDER WITH ANGIOTENSIN CONVERTING ENZYME 2